Carregant...
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
The risk of hepatocellular carcinoma recurrence is universal regardless of the treatment modality applied, and secondary prevention is still an unmet issue even though the elimination of hepatitis C (HCV) with direct antiviral agents (DAAs) was expected to be one of the new options. Unfortunately, t...
Guardat en:
| Publicat a: | Viruses |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563506/ https://ncbi.nlm.nih.gov/pubmed/31052463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11050406 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|